KalshiCheck availabilityKYC required2% feeVerified resolution dataFairly calibratedCurrent implied probability
BPC-157 79%Leader of 7 outcomes
Market quality
41 / 100
Low quality24h Volume
—
Liquidity
$1.1K
Low liquiditySpread
4.0 pt
Moderate spreadMarket data
Updated 4 minutes ago
Jul 28, 26, 4:30 PM UTCOct 1, 27, 3:59 AM UTC
Trends
Related Markets
Related questions for context, not a comparison of equivalent contracts.
Miami-Dade WASD ceases adding fluoride to its drinking water by 2027
Manifold MarketsHantavirus pandemic in 2026?
PolymarketMeasles cases in 2026?
KalshiWhat will Trump say during his announcement on healthcare?
KalshiHeidi Overton confirmed as FDA Commissioner by which date?
PolymarketHantavirus vaccine in 2026?
PolymarketRules
If the U.S. Food and Drug Administration announces publication of a proposed rule that would add BPC-157 (free base) or BPC-157 acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.
Settles via:U.S. Food and Drug Administration
- If the U.S. Food and Drug Administration announces publication of a proposed rule that would add KPV (free base) or KPV acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.
- If the U.S. Food and Drug Administration announces publication of a proposed rule that would add TB-500 (free base) or TB-500 acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.
- If the U.S. Food and Drug Administration announces publication of a proposed rule that would add MOTS-c (free base) or MOTS-c acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.
- If the U.S. Food and Drug Administration announces publication of a proposed rule that would add Semax (free base) or Semax acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.
- If the U.S. Food and Drug Administration announces publication of a proposed rule that would add Epitalon (free base) or Epitalon acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.
Frequently asked questions
- What are the current odds for Which peptides will the FDA propose adding to the 503A Bulks List??
- Kalshi prices BPC-157 at 79% as of September 18, 2026.
- When does Which peptides will the FDA propose adding to the 503A Bulks List? resolve?
- Which peptides will the FDA propose adding to the 503A Bulks List? is scheduled to resolve on October 1, 2027.
- How is Which peptides will the FDA propose adding to the 503A Bulks List? settled?
- Kalshi settles this market as follows: If the U.S. Food and Drug Administration announces publication of a proposed rule that would add BPC-157 (free base) or BPC-157 acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.